MFN2 and Charcot-Marie-Tooth disease type 2A1: Furthermore, it was demonstrated that the developed iPSC-derived neurons are true hallmarks of CMT2A since the CRISPR/Cas9 correction of the pathogenic Mitofusin 2 MFN2-R94Q patient iPSC line prevents the characteristic disease phenotypes.